Abstract
Late preterm infants are defined as those born between 340/0 and 366/7 weeks of gestation. This population represents a growing proportion of preterm deliveries and traditionally has been neglected as thought to behave similarly to term infants. However, studies in the last decade have shown that they are vulnerable not only during the first few weeks of life but also later on in infancy and childhood. The aim of this review is to summarize the published literature in the field of the long-term outcomes of the late preterm delivery. The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively. Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field. Continuous efforts should also be made so that the needs of these infants are recognized and managed in a timely appropriate manner.
Keywords: Late preterm, infants, long-term, outcome.
Current Pediatric Reviews
Title:Long-Term Outcome of Infants Born Late Preterm
Volume: 10 Issue: 4
Author(s): Despoina Gkentzi and Gabriel Dimitriou
Affiliation:
Keywords: Late preterm, infants, long-term, outcome.
Abstract: Late preterm infants are defined as those born between 340/0 and 366/7 weeks of gestation. This population represents a growing proportion of preterm deliveries and traditionally has been neglected as thought to behave similarly to term infants. However, studies in the last decade have shown that they are vulnerable not only during the first few weeks of life but also later on in infancy and childhood. The aim of this review is to summarize the published literature in the field of the long-term outcomes of the late preterm delivery. The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively. Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field. Continuous efforts should also be made so that the needs of these infants are recognized and managed in a timely appropriate manner.
Export Options
About this article
Cite this article as:
Gkentzi Despoina and Dimitriou Gabriel, Long-Term Outcome of Infants Born Late Preterm, Current Pediatric Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573400510666141114224257
DOI https://dx.doi.org/10.2174/1573400510666141114224257 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction
CNS & Neurological Disorders - Drug Targets Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections:
Recent Patents on Biotechnology Critical Role of the Endocannabinoid System in the Regulation of Food Intake and Energy Metabolism, with Phylogenetic, Developmental, and Pathophysiological Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Engineering of Conotoxins for the Treatment of Pain
Current Pharmaceutical Design Modulation of Potassium Channels as a Therapeutic Approach
Current Pharmaceutical Design Pharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders
CNS & Neurological Disorders - Drug Targets Immune Functions of Glia and Neurons in the Central Nervous System
Current Immunology Reviews (Discontinued) Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations
CNS & Neurological Disorders - Drug Targets A Mini Review on Central Nervous System Potential of Isatin Derivatives
Central Nervous System Agents in Medicinal Chemistry Design, Synthesis and in silico Studies of New 5-substituted-2-(2-(5-aryl- 1H-1, 2, 4-triazole-3-ylthio) acetyl) Hydrazine Carbothioamide/ Carboxamides for Anticonvulsant Activity
Letters in Drug Design & Discovery New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Metabotropic Glutamate Receptors in the Control of Mood Disorders
CNS & Neurological Disorders - Drug Targets Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s
Current Medicinal Chemistry Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors
Current Pharmaceutical Design Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer’s Disease
Current Protein & Peptide Science Social Behavior as an Endophenotype for Psychiatric Disorders Development of Mouse Models
Current Genomics Interaction of Different Proteins with GABA<sub>A</sub> Receptor and their Modulatory Effect on Inhibitory Neural Transmission Leads to Epilepsy
CNS & Neurological Disorders - Drug Targets Recent Developments of Thalidomide Derivatives Possessing Anti-Inflammatory Activity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry